Key players within the pharmaceutical industry are conspiring with one another to artificially inflate the price of insulin by more than 1,000 percent, and Texas Attorney General Ken Paxton is suing them to try to stop it.
In a statement, Paxton revealed that Big Pharma is attempting to take full advantage of diabetes patients by driving up insulin prices as high as they possibly can, money and lots of it being the "cure" for the pharmaceutical industry's insatiable greed problem.
"This is a disturbing conspiracy by which pharmaceutical companies were intentionally and artificially inflating the price of insulin," Paxton tweeted. "Big Pharma insulin manufacturers and PBMs worked together to take advantage of diabetes patients and drive prices as high as they could."
"These companies acted illegally and unethically to enrich themselves, and we will hold them accountable."
(Related: Did you know that insulin injections more than double the risk of death in type 2 diabetics?)
What about COVID jabs?
Paxton specifically called out pharmacy benefit managers, including Eli Lilly, Express Scripts and CVS Pharmacy, as the co-conspirators in this insulin racket, which will price many diabetics out of their medicine.
"Through this conspiracy, the manufacturers artificially and willingly raised the prices of insulin then [sic] paid a significant, undisclosed portion back to the PBMs as a quid pro quo for inclusion in the PBMs' standard offerings," he says.
"The PBMs then granted preferred status to the manufacturer whose drug has the highest list price while excluding lower priced drugs. These synthetic insulin drugs, which today cost the manufacturers less than $2 to produce and were originally priced at $20 when released in the late 1990s, now range between $300 and $700."
According to Paxton, what these pharmaceutical giants are doing violates the Texas Deceptive Trade Practices Act, constitutes unjust enrichment, and represents an unlawful civil conspiracy.
"While the PBM Defendants represent that they perform their services on behalf of their clients (including Texas payors) and diabetics to lower drug prices, increase access to affordable drugs, and promote diabetic health, these representations are false," the defendants in Paxton's case argue in their defense.
"Rather, the PBM Defendants have worked in coordination with the Manufacturer Defendants to distort the market for diabetic treatments to their benefit at the expense of Texas diabetics and payors."
Paxton remains painfully silent about the damage the pharmaceutical industry caused to humanity with its Wuhan coronavirus (COVID-19) "vaccines." Some are wondering if he plans to go after them, too, once he gets done with this lawsuit.
"When you have time, sue the hell out of Moderna for their one hit wonder myocarditis epidemic gene therapy vaccine," wrote one person on X / Twitter. "7.7% of the recipients of the gift that keeps on giving have had their lives changed forever thanks to false assertions of safe and effective."
Another called on Paxton to take a closer look at the root causes of diabetes and address those rather than just make a big deal about the cost of treating the symptoms.
"Now look towards the question as to why we have the health problem to begin with," this user said. "We can't keep slapping bandaids on everything."
The Health Ranger gave a shoutout to Paxton calling what he is doing to fight insulin price gouging "Outstanding!"
"All of these companies need to be held accountable for their corruption," wrote another.
"We recently paid about $12 for a topical rosacea skin medicine in eastern Europe," told another about how much cheaper drugs are overseas compared to here in the U.S.
"Identical med brand formula and manufacturer costs well over $110 here in the U.S. No generic available in U.S. Medicare only covers this in a foam, not the gel. Will be buying several more next time we visit the in-laws."
More related news about pharmaceutical industry corruption can be found at BadMedicine.news.
Sources for this article include:
Please contact us for more information.